| |
|
|
|
Altimmune Inc.  
|
|
22.35 2.13 (0.11%) |
07-10 16:00 |
|
Open: |
19.485 |
Pre close: |
20.22 |
Target:
|
28.79
|
|
High: |
24.39 |
Low: |
19.3235 |
Resistance:
|
24.65
28.79
|
|
Volume: |
17,919,549 |
Market Cap: |
483M |
Support:
|
12.95
5.71
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
16.14
 |
MACD |
MACD(12,26):
|
2.88 |
|
MA(20): |
10.60 |
Signal(12,26,9): |
1.64 |
|
MA(100): |
5.31 |
Stochastic Oscillator |
%K(14,3):
|
78.55 |
|
MA(250): |
3.30 |
%D(3): |
73.03 |
|
Average Volume(K) |
3-Month: |
451327
|
52-Week |
High:
|
24.65 |
|
10-Days: |
1162117 |
Low: |
1.51 |
|
RSI |
RSI(14):
|
89.05 |
Change(%): |
804.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.530 |
Return on Equity (ttm) |
-44.1 |
Shares Out. (M) |
20.11 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-24.0 |
Shares Float (M) |
10.43 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
17.11 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-25.1 |
% Held by Institutions |
8.38 |
|
Forward EPS |
-1.600 |
Gross Profit (p.s.) |
-0.561 |
Shares Short (K) |
2640 |
|
Book Value (p.s.) |
2.770 |
EBITDA (p.s.) |
-1.129 |
P/E |
-14.61 |
|
Sales Per Share |
0.252 |
Qtrly Earnings Growth |
0.00 |
P/BV |
8.07 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-11.84 |
P/S |
88.82 |
|
Operating Margin |
-454.94 |
Levered Free Cash Flow
(M) |
-12.10 |
P/CF |
-37.96 |
|
|
|
|
|
|
